Oxoid Limited is recalling 1,406 units of its Levofloxacin Susceptibility Discs (Lev5) because the packaging may actually contain Norfloxacin discs. These discs are laboratory tools used by healthcare professionals to determine which antibiotics will effectively treat a patient's bacterial infection. No injuries or incidents have been reported in connection with this mislabeling.
The use of mislabeled discs can lead to incorrect laboratory test results. This could cause a patient to be treated with the wrong antibiotic or an ineffective medication for their specific infection.
Packaging for Levofloxacin may contain Norfloxacin Antimicrobial Susceptibility discs.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.